Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 149 entries
Sorted by: Best Match Show Resources per page
Gene expression in pediatric heart disease with emphasis on conotruncal defects.

Progress in pediatric cardiology

Bittel DC, Kibiryeva N, O'Brien JE, Lofland GK, Butler MG.
PMID: 28529438
Prog Pediatr Cardiol. 2005 Jul;20(2):127-141. doi: 10.1016/j.ppedcard.2005.04.004. Epub 2005 Jun 09.

Developmental abnormalities of the heart are the underlying cause of many congenital heart malformations. The embryological development of the integrated cardiovascular tissue is the result of multiple tissue and cell-to-cell interactions involving temporal and spatial events under genetic control....

Cite
Bittel DC, Kibiryeva N, O'Brien JE, et al. Gene expression in pediatric heart disease with emphasis on conotruncal defects. Prog Pediatr Cardiol. 2005;20(2):127-141doi: 10.1016/j.ppedcard.2005.04.004.
Bittel, D. C., Kibiryeva, N., O'Brien, J. E., Lofland, G. K., & Butler, M. G. (2005). Gene expression in pediatric heart disease with emphasis on conotruncal defects. Progress in pediatric cardiology, 20(2), 127-141. https://doi.org/10.1016/j.ppedcard.2005.04.004
Bittel, Douglas C, et al. "Gene expression in pediatric heart disease with emphasis on conotruncal defects." Progress in pediatric cardiology vol. 20,2 (2005): 127-141. doi: https://doi.org/10.1016/j.ppedcard.2005.04.004
Bittel DC, Kibiryeva N, O'Brien JE, Lofland GK, Butler MG. Gene expression in pediatric heart disease with emphasis on conotruncal defects. Prog Pediatr Cardiol. 2005 Jul;20(2):127-141. doi: 10.1016/j.ppedcard.2005.04.004. Epub 2005 Jun 09. PMID: 28529438; PMCID: PMC5436709.
Copy Download .nbib Format: NLM
PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY.

Progress in pediatric cardiology

Devarajan P, Jefferies JL.
PMID: 27429539
Prog Pediatr Cardiol. 2016 Jun;41:33-40. doi: 10.1016/j.ppedcard.2015.12.006.

The incidence of chronic kidney disease (CKD) in children and adults is increasing. Cardiologists have become indispensable members of the care provider team for children with CKD. This is partly due to the high incidence of CKD in children...

Cite
Devarajan P, Jefferies JL. PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY. Prog Pediatr Cardiol. 2016;41:33-40doi: 10.1016/j.ppedcard.2015.12.006.
Devarajan, P., & Jefferies, J. L. (2016). PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY. Progress in pediatric cardiology, 4133-40. https://doi.org/10.1016/j.ppedcard.2015.12.006
Devarajan, Prasad, and Jefferies, John Lynn. "PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY." Progress in pediatric cardiology vol. 41 (2016): 33-40. doi: https://doi.org/10.1016/j.ppedcard.2015.12.006
Devarajan P, Jefferies JL. PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY. Prog Pediatr Cardiol. 2016 Jun;41:33-40. doi: 10.1016/j.ppedcard.2015.12.006. PMID: 27429539; PMCID: PMC4943846.
Copy Download .nbib Format: NLM
Clinical pharmacology research in the pediatric patient: the challenge continues.

Progress in pediatric cardiology

Ten Eick AP, Reed MD.
PMID: 11114544
Prog Pediatr Cardiol. 2000 Nov 04;12(1):29-35. doi: 10.1016/s1058-9813(00)00056-4.

For most of the 20th century, most drugs labeled by the United States Food and Drug Administration (USFDA) have not been adequately studied in the pediatric population. This lack of data has necessitated the continued dependence of practitioners on...

Cite
Ten Eick AP, Reed MD. Clinical pharmacology research in the pediatric patient: the challenge continues. Prog Pediatr Cardiol. 2000;12(1):29-35doi: 10.1016/s1058-9813(00)00056-4.
Ten Eick AP, & Reed, M. D. (2000). Clinical pharmacology research in the pediatric patient: the challenge continues. Progress in pediatric cardiology, 12(1), 29-35. https://doi.org/10.1016/s1058-9813(00)00056-4
Ten Eick AP, and Reed. "Clinical pharmacology research in the pediatric patient: the challenge continues." Progress in pediatric cardiology vol. 12,1 (2000): 29-35. doi: https://doi.org/10.1016/s1058-9813(00)00056-4
Ten Eick AP, Reed MD. Clinical pharmacology research in the pediatric patient: the challenge continues. Prog Pediatr Cardiol. 2000 Nov 04;12(1):29-35. doi: 10.1016/s1058-9813(00)00056-4. PMID: 11114544.
Copy Download .nbib Format: NLM
Digitalis use in children: an uncertain future.

Progress in pediatric cardiology

Hougen TJ.
PMID: 11114545
Prog Pediatr Cardiol. 2000 Nov 04;12(1):37-43. doi: 10.1016/s1058-9813(00)00057-6.

The therapeutic indications for digoxin in the treatment of children with large left-to-right shunts continue to be reassessed. New insights into the alterations in cardiac function imposed by this hemodynamic burden have shown preserved systolic performance. Pharmacological interventions that...

Cite
Hougen TJ. Digitalis use in children: an uncertain future. Prog Pediatr Cardiol. 2000;12(1):37-43doi: 10.1016/s1058-9813(00)00057-6.
Hougen, T. J. (2000). Digitalis use in children: an uncertain future. Progress in pediatric cardiology, 12(1), 37-43. https://doi.org/10.1016/s1058-9813(00)00057-6
Hougen. "Digitalis use in children: an uncertain future." Progress in pediatric cardiology vol. 12,1 (2000): 37-43. doi: https://doi.org/10.1016/s1058-9813(00)00057-6
Hougen TJ. Digitalis use in children: an uncertain future. Prog Pediatr Cardiol. 2000 Nov 04;12(1):37-43. doi: 10.1016/s1058-9813(00)00057-6. PMID: 11114545.
Copy Download .nbib Format: NLM
Vasodilators in the treatment of pediatric heart failure.

Progress in pediatric cardiology

Balaguru D, Auslender M.
PMID: 11114548
Prog Pediatr Cardiol. 2000 Nov 04;12(1):81-90. doi: 10.1016/s1058-9813(00)00060-6.

The goals of heart failure therapy have shifted from purely hemodynamic manipulation to a combination of hemodynamic and neurohumoral modulation. Vasodilators with neurohumoral modulatory properties [such as ACE inhibitors (ACEi) and third generation beta-blockers] have become the cornerstone of...

Cite
Balaguru D, Auslender M. Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol. 2000;12(1):81-90doi: 10.1016/s1058-9813(00)00060-6.
Balaguru, D., & Auslender, M. (2000). Vasodilators in the treatment of pediatric heart failure. Progress in pediatric cardiology, 12(1), 81-90. https://doi.org/10.1016/s1058-9813(00)00060-6
Balaguru, and Auslender. "Vasodilators in the treatment of pediatric heart failure." Progress in pediatric cardiology vol. 12,1 (2000): 81-90. doi: https://doi.org/10.1016/s1058-9813(00)00060-6
Balaguru D, Auslender M. Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol. 2000 Nov 04;12(1):81-90. doi: 10.1016/s1058-9813(00)00060-6. PMID: 11114548.
Copy Download .nbib Format: NLM
Prospects for gene therapy for inherited cardiomyopathies.

Progress in pediatric cardiology

Bowles NE, Bowles K, Towbin JA.
PMID: 11114553
Prog Pediatr Cardiol. 2000 Nov 04;12(1):133-145. doi: 10.1016/s1058-9813(00)00065-5.

Over the last few years the genes responsible for a number of genetic diseases of the cardiovascular system have been identified. These have included X-linked and autosomal dominant dilated cardiomyopathy, and hypertrophic cardiomyopathy. Genetic heterogeneity has been described in...

Cite
Bowles NE, Bowles K, Towbin JA. Prospects for gene therapy for inherited cardiomyopathies. Prog Pediatr Cardiol. 2000;12(1):133-145doi: 10.1016/s1058-9813(00)00065-5.
Bowles, N. E., Bowles, K., & Towbin, J. A. (2000). Prospects for gene therapy for inherited cardiomyopathies. Progress in pediatric cardiology, 12(1), 133-145. https://doi.org/10.1016/s1058-9813(00)00065-5
Bowles, et al. "Prospects for gene therapy for inherited cardiomyopathies." Progress in pediatric cardiology vol. 12,1 (2000): 133-145. doi: https://doi.org/10.1016/s1058-9813(00)00065-5
Bowles NE, Bowles K, Towbin JA. Prospects for gene therapy for inherited cardiomyopathies. Prog Pediatr Cardiol. 2000 Nov 04;12(1):133-145. doi: 10.1016/s1058-9813(00)00065-5. PMID: 11114553.
Copy Download .nbib Format: NLM
Cardiopulmonary interactions in children with congenital heart disease: physiology and clinical correlates.

Progress in pediatric cardiology

Kocis KC, Meliones JN.
PMID: 10978713
Prog Pediatr Cardiol. 2000 Sep 01;11(3):203-210. doi: 10.1016/s1058-9813(00)00051-5.

Cardiopulmonary interaction is the term that is used to describe the inseparable connection between the heart and lungs. In health, the cardiovascular and pulmonary systems are in perfect balance. In disease, derangements of either system leads to dysfunction in...

Cite
Kocis KC, Meliones JN. Cardiopulmonary interactions in children with congenital heart disease: physiology and clinical correlates. Prog Pediatr Cardiol. 2000;11(3):203-210doi: 10.1016/s1058-9813(00)00051-5.
Kocis, K. C., & Meliones, J. N. (2000). Cardiopulmonary interactions in children with congenital heart disease: physiology and clinical correlates. Progress in pediatric cardiology, 11(3), 203-210. https://doi.org/10.1016/s1058-9813(00)00051-5
Kocis, and Meliones. "Cardiopulmonary interactions in children with congenital heart disease: physiology and clinical correlates." Progress in pediatric cardiology vol. 11,3 (2000): 203-210. doi: https://doi.org/10.1016/s1058-9813(00)00051-5
Kocis KC, Meliones JN. Cardiopulmonary interactions in children with congenital heart disease: physiology and clinical correlates. Prog Pediatr Cardiol. 2000 Sep 01;11(3):203-210. doi: 10.1016/s1058-9813(00)00051-5. PMID: 10978713.
Copy Download .nbib Format: NLM
Evaluation and treatment of syncope in infants.

Progress in pediatric cardiology

Kochilas L, Tanel RE.
PMID: 11457676
Prog Pediatr Cardiol. 2001 Aug;13(2):71-82. doi: 10.1016/s1058-9813(01)00090-x.

Syncope in the infant and newborn occurs as a loss of consciousness due to a variety of etiologies. Because syncope at this age may be a harbinger of sudden infant death, the symptom provokes anxiety and challenges clinicians to...

Cite
Kochilas L, Tanel RE. Evaluation and treatment of syncope in infants. Prog Pediatr Cardiol. 2001;13(2):71-82doi: 10.1016/s1058-9813(01)00090-x.
Kochilas, L., & Tanel, R. E. (2001). Evaluation and treatment of syncope in infants. Progress in pediatric cardiology, 13(2), 71-82. https://doi.org/10.1016/s1058-9813(01)00090-x
Kochilas, L, and Tanel, R E.. "Evaluation and treatment of syncope in infants." Progress in pediatric cardiology vol. 13,2 (2001): 71-82. doi: https://doi.org/10.1016/s1058-9813(01)00090-x
Kochilas L, Tanel RE. Evaluation and treatment of syncope in infants. Prog Pediatr Cardiol. 2001 Aug;13(2):71-82. doi: 10.1016/s1058-9813(01)00090-x. PMID: 11457676.
Copy Download .nbib Format: NLM
Evaluation of syncope in adult congenital heart disease.

Progress in pediatric cardiology

Daniels CJ, Chan DP.
PMID: 11457677
Prog Pediatr Cardiol. 2001 Aug;13(2):83-90. doi: 10.1016/s1058-9813(01)00091-1.

Approximately one million adults in the United States have congenital heart disease. The practitioner who sees one of these patients presenting with syncope must have a thorough understanding of: the underlying disease process; the associated congenital heart abnormalities; the...

Cite
Daniels CJ, Chan DP. Evaluation of syncope in adult congenital heart disease. Prog Pediatr Cardiol. 2001;13(2):83-90doi: 10.1016/s1058-9813(01)00091-1.
Daniels, C. J., & Chan, D. P. (2001). Evaluation of syncope in adult congenital heart disease. Progress in pediatric cardiology, 13(2), 83-90. https://doi.org/10.1016/s1058-9813(01)00091-1
Daniels, C J., and Chan, D P.. "Evaluation of syncope in adult congenital heart disease." Progress in pediatric cardiology vol. 13,2 (2001): 83-90. doi: https://doi.org/10.1016/s1058-9813(01)00091-1
Daniels CJ, Chan DP. Evaluation of syncope in adult congenital heart disease. Prog Pediatr Cardiol. 2001 Aug;13(2):83-90. doi: 10.1016/s1058-9813(01)00091-1. PMID: 11457677.
Copy Download .nbib Format: NLM
Costs and utility of tests in the evaluation of the pediatric patients with syncope.

Progress in pediatric cardiology

Steinberg LA, Knilans TK.
PMID: 11457683
Prog Pediatr Cardiol. 2001 Aug;13(2):139-149. doi: 10.1016/s1058-9813(01)00097-2.

New diagnostic tests have markedly improved the ability to establish a cause of syncope in pediatric patients, but at a substantial cost. The goal of syncope evaluation should be to diagnose treatable causes and identify patients at high risk...

Cite
Steinberg LA, Knilans TK. Costs and utility of tests in the evaluation of the pediatric patients with syncope. Prog Pediatr Cardiol. 2001;13(2):139-149doi: 10.1016/s1058-9813(01)00097-2.
Steinberg, L. A., & Knilans, T. K. (2001). Costs and utility of tests in the evaluation of the pediatric patients with syncope. Progress in pediatric cardiology, 13(2), 139-149. https://doi.org/10.1016/s1058-9813(01)00097-2
Steinberg, L A., and Knilans, T K.. "Costs and utility of tests in the evaluation of the pediatric patients with syncope." Progress in pediatric cardiology vol. 13,2 (2001): 139-149. doi: https://doi.org/10.1016/s1058-9813(01)00097-2
Steinberg LA, Knilans TK. Costs and utility of tests in the evaluation of the pediatric patients with syncope. Prog Pediatr Cardiol. 2001 Aug;13(2):139-149. doi: 10.1016/s1058-9813(01)00097-2. PMID: 11457683.
Copy Download .nbib Format: NLM
Antiarrhythmic drug therapy in the neonate.

Progress in pediatric cardiology

Dubin A.
PMID: 10822190
Prog Pediatr Cardiol. 2000 May 01;11(1):55-63. doi: 10.1016/s1058-9813(00)00036-9.

The neonate presents a challenge for the practitioner considering antiarrhythmic therapy: pharmacokinetics are different than in older children or adults; and the arrhythmia substrate may also differ, with respect to issues of ion channel and autonomic nervous system development....

Cite
Dubin A. Antiarrhythmic drug therapy in the neonate. Prog Pediatr Cardiol. 2000;11(1):55-63doi: 10.1016/s1058-9813(00)00036-9.
Dubin, A. (2000). Antiarrhythmic drug therapy in the neonate. Progress in pediatric cardiology, 11(1), 55-63. https://doi.org/10.1016/s1058-9813(00)00036-9
Dubin. "Antiarrhythmic drug therapy in the neonate." Progress in pediatric cardiology vol. 11,1 (2000): 55-63. doi: https://doi.org/10.1016/s1058-9813(00)00036-9
Dubin A. Antiarrhythmic drug therapy in the neonate. Prog Pediatr Cardiol. 2000 May 01;11(1):55-63. doi: 10.1016/s1058-9813(00)00036-9. PMID: 10822190.
Copy Download .nbib Format: NLM
A method for preventive cardiology in children.

Progress in pediatric cardiology

Goldberg CS, Samyn MM.
PMID: 11223342
Prog Pediatr Cardiol. 2001 Jan;12(2):155-160. doi: 10.1016/s1058-9813(00)00068-0.

There are clear indications for prevention of atherosclerotic disease to begin in childhood. Optimal primary prevention will utilize a public health strategy. For children with elevated risk for atherosclerotic disease a clinically based prevention program is helpful. The indications...

Cite
Goldberg CS, Samyn MM. A method for preventive cardiology in children. Prog Pediatr Cardiol. 2001;12(2):155-160doi: 10.1016/s1058-9813(00)00068-0.
Goldberg, C. S., & Samyn, M. M. (2001). A method for preventive cardiology in children. Progress in pediatric cardiology, 12(2), 155-160. https://doi.org/10.1016/s1058-9813(00)00068-0
Goldberg, C S., and Samyn, M M.. "A method for preventive cardiology in children." Progress in pediatric cardiology vol. 12,2 (2001): 155-160. doi: https://doi.org/10.1016/s1058-9813(00)00068-0
Goldberg CS, Samyn MM. A method for preventive cardiology in children. Prog Pediatr Cardiol. 2001 Jan;12(2):155-160. doi: 10.1016/s1058-9813(00)00068-0. PMID: 11223342.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 149 entries